Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Estrogen carcinogenesis in breast cancer.

Literature DB >> 16421368

Estrogen carcinogenesis in breast cancer.

James D Yager¹, Nancy E Davidson.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2006 PMID： 16421368 DOI： 10.1056/NEJMra050776

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

614 in total

1. Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women.

Authors: A Heather Eliassen; Donna Spiegelman; Xia Xu; Larry K Keefer; Timothy D Veenstra; Robert L Barbieri; Walter C Willett; Susan E Hankinson; Regina G Ziegler
Journal: Cancer Res Date: 2011-12-05 Impact factor: 12.701

2. Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer.

Authors: Bhupendra Singh; Nimee K Bhat; Hari K Bhat
Journal: Carcinogenesis Date: 2011-11-09 Impact factor: 4.944

3. Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer.

Authors: Vei Mah; Diana Marquez; Mohammad Alavi; Erin L Maresh; Li Zhang; Nam Yoon; Steve Horvath; Lora Bagryanova; Michael C Fishbein; David Chia; Richard Pietras; Lee Goodglick
Journal: Lung Cancer Date: 2011-04-20 Impact factor: 5.705

4. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.

Authors: Garnet L Anderson; Rowan T Chlebowski; Aaron K Aragaki; Lewis H Kuller; JoAnn E Manson; Margery Gass; Elizabeth Bluhm; Stephanie Connelly; F Allan Hubbell; Dorothy Lane; Lisa Martin; Judith Ockene; Thomas Rohan; Robert Schenken; Jean Wactawski-Wende
Journal: Lancet Oncol Date: 2012-03-07 Impact factor: 41.316

10. Genistein affects HER2 protein concentration, activation, and promoter regulation in BT-474 human breast cancer cells.

Authors: Mary S Sakla; Nader S Shenouda; Pete J Ansell; Ruth S Macdonald; Dennis B Lubahn
Journal: Endocrine Date: 2007-10-02 Impact factor: 3.633

Estrogen carcinogenesis in breast cancer.

1. Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women.

2. Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer.

3. Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer.

4. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.

5. Mammographic Density and Circulating Sex Hormones: a Cross-Sectional Study in Postmenopausal Korean Women.

6. Pre-diagnostic sex hormone levels and survival among breast cancer patients.

Review 7. Obesity, energy balance, and cancer: new opportunities for prevention.

8. IRP2 regulates breast tumor growth.

9. Coexposure to phytoestrogens and bisphenol a mimics estrogenic effects in an additive manner.

10. Genistein affects HER2 protein concentration, activation, and promoter regulation in BT-474 human breast cancer cells.